20-Dec-2024 3:00 PM CST - Business Wire Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024 Aptorum Group Limited (NASDAQ: APM) (Aptorum Group or the Company), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2024. Our team and Yoov have spent considerable time and effort on the due diligence process, the negotiation of definitive terms, and the preparation of necessary tra
20-Dec-2024 3:00 PM CST - Business Wire Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024 Aptorum Group Limited (NASDAQ: APM) (Aptorum Group or the Company), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2024. Our team and Yoov have spent considerable time and effort on the due diligence process, the negotiation of definitive terms, and the preparation of necessary tra
